Amedisys, Inc. (NASDAQ:AMED) Shares Bought by Cwm LLC

Cwm LLC lifted its holdings in Amedisys, Inc. (NASDAQ:AMED) by 40.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,629 shares of the health services provider’s stock after purchasing an additional 757 shares during the period. Cwm LLC’s holdings in Amedisys were worth $250,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. grew its stake in shares of Amedisys by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 3,241,160 shares of the health services provider’s stock worth $302,724,000 after purchasing an additional 12,137 shares during the last quarter. Pentwater Capital Management LP grew its stake in shares of Amedisys by 239.5% in the 3rd quarter. Pentwater Capital Management LP now owns 1,144,000 shares of the health services provider’s stock worth $106,850,000 after purchasing an additional 807,000 shares during the last quarter. Alpine Associates Management Inc. grew its stake in shares of Amedisys by 46.6% in the 3rd quarter. Alpine Associates Management Inc. now owns 1,033,497 shares of the health services provider’s stock worth $96,529,000 after purchasing an additional 328,300 shares during the last quarter. Westchester Capital Management LLC grew its stake in shares of Amedisys by 269.7% in the 3rd quarter. Westchester Capital Management LLC now owns 850,386 shares of the health services provider’s stock worth $79,426,000 after purchasing an additional 620,386 shares during the last quarter. Finally, Grantham Mayo Van Otterloo & Co. LLC increased its position in shares of Amedisys by 215.9% in the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 314,914 shares of the health services provider’s stock worth $29,413,000 after acquiring an additional 215,233 shares in the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on AMED. StockNews.com raised shares of Amedisys from a “hold” rating to a “buy” rating in a research report on Saturday. Cantor Fitzgerald reissued a “neutral” rating and issued a $101.00 target price on shares of Amedisys in a research report on Thursday, April 25th. Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a research report on Tuesday, March 26th. Finally, Royal Bank of Canada boosted their price objective on shares of Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, March 25th. Seven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $97.50.

Amedisys Stock Down 0.4 %

Shares of NASDAQ AMED opened at $92.08 on Friday. The firm has a market capitalization of $3.01 billion, a PE ratio of -143.88, a price-to-earnings-growth ratio of 3.42 and a beta of 0.84. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.31. Amedisys, Inc. has a 1 year low of $73.10 and a 1 year high of $96.44. The firm’s 50-day moving average is $92.40 and its 200-day moving average is $93.33.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.01. The company had revenue of $571.41 million for the quarter, compared to analyst estimates of $565.38 million. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.00 EPS. Equities analysts expect that Amedisys, Inc. will post 4.57 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.